EQS-Adhoc: Cytos Biotechnology AG: Invitation for an Extraordinary Shareholders’ Meeting

19.02.2015 / 07:00 Release of an ad hoc announcement pursuant to Art. 53 KR. The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------

Cytos Biotechnology Ltd. invites for an Extraordinary Shareholders' Meeting

Schlieren (Zurich), Switzerland, February 19, 2015 - Cytos Biotechnology Ltd ("Cytos" or "the Company"), announced today that an Extraordinary Shareholders' Meeting will take place on Monday, March 16, 2015 at 10 a.m. at Cytos' offices in Schlieren/Zurich (Switzerland).

At this meeting, shareholders will be invited to approve the share capital increase which is needed to create the shares for the conversion of the convertible bonds into equity. Further, the conditional and authorized capital shall be amended.

The formal invitation to the meeting will be sent out within the next few days and can also be downloaded on the following website:

http://www.cytos.com/uploads/2015/EGM2015.pdf

For further information, please contact:

Cytos Biotechnology Ltd Harry Welten, MBA Chief Financial Officer Tel: +41 44 733 46 46 harry.welten@cytos.com

About Cytos Biotechnology Ltd

Continued here:
EQS-Adhoc: Cytos Biotechnology AG: Invitation for an Extraordinary Shareholders' Meeting